STAND UP TO CANCER LAUNCHES NEW RADIO PSA WITH JAZZ PHARMACEUTICALS TO ENCOURAGE LUNG CANCER SCREENINGPRNewsWire • 11/14/22
Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 11/10/22
Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-pointPRNewsWire • 11/09/22
Why Jazz Pharmaceuticals (JAZZ) Might Surprise This Earnings SeasonZacks Investment Research • 11/08/22
Jazz Pharmaceuticals to Present Data at 2022 ASH Meeting Showcasing Commitment to Advancing Oncology ResearchPRNewsWire • 11/03/22
Jazz Pharmaceuticals to Report 2022 Third Quarter Financial Results on November 9, 2022PRNewsWire • 10/26/22
Wall Street Analysts Predict a 48% Upside in Jazz (JAZZ): Here's What You Should KnowZacks Investment Research • 10/24/22
Zymeworks To Host Conference Call on Exclusive Licensing Agreement of ZanidatamabBusiness Wire • 10/19/22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific AntibodyPRNewsWire • 10/19/22
Jazz Pharmaceuticals to Present Advancements in Sleep Medicine at Psych Congress 2022PRNewsWire • 09/15/22
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 09/14/22